|
|
||||||||
,
,¶,**,







,
,¶,

* Laboratory of Cellular Immunobiology,
Laboratory of Tumor Immunology,
Allogeneic Blood and Marrow Transplantation and
Clinical Immunology Services,
¶
Division of Hematologic Oncology, Department of Medicine,
||
Biostatistics Service, Department of Biostatistics and Epidemiology,
#
Laboratory of Gene Transfer and Gene Expression, Gene Transfer and Somatic Cell Engineering Facility,
**
Immunology Program, Memorial Sloan-Kettering Cancer Center, and

Weill Medical College of Cornell University, New York, NY 10021
Oncoretroviral vectors encoding either full-length Ag or a corresponding immunodominant peptide were expressed in Langerhans-type dendritic cells (LCs) differentiated from CD34+ progenitors. We used human CMV as a model Ag restricted by HLA-A*0201 to define parameters for eventual expression of cancer Ags by LCs for active immunization against tumors. Stimulation by CMVpp65495503-pulsed LCs, CMVpp65495503-transduced LCs, and full-length CMVpp65-transduced LCs respectively increased tetramer-reactive T cells with an effector memory phenotype by 10 ± 11, 34 ± 21, and 51 ± 24-fold (p < 0.05) from CMV-seropositive donors. CMV-specific CD8+ CTLs achieved respective frequencies of 231 ± 102, 583 ± 219, and 714 ± 281 spot-forming cells per 105 input cells (p < 0.01) in ELISPOT assays for IFN-
secretion. LCs expressing full-length Ag stimulated greater lytic activity than either peptide-transduced or peptide-pulsed LCs (p < 0.05), all in the absence of exogenous cytokines. pp65-transduced LCs presenting class I and II MHC-restricted epitopes expanded IFN-
-secreting CD4+ T cells, whereas pp65495503-transduced LCs did not. CD4+ T cell numbers even declined after stimulation by pp65495503 peptide-pulsed LCs. CD4+ T cell depletion confirmed their contribution to the more robust CTL responses. LCs, transduced with a retroviral vector encoding full-length Ag, stimulate potent CTLs directed against multiple epitopes in a CD4+ Th cell-dependent manner.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |